Edit Content
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Ocular Drug Delivery Market to reach USD xxx billion by the end of 2030.

Global Ocular Drug Delivery Market Size study & Forecast, by Technology (Topical, Iontophoresis, Ocular Insert, Intraocular Implants, In Situ Gel Punctal Plugs, Others), by Formulation Type (Liposomes Nanoparticles, Solution, Emulsion, Suspension, Ointment), by Disease Type (Glaucoma, Diabetic Retinopathy, Dry Eye Syndrome, Macular Degeneration, Cataract, Others) and by End User (Hospitals, Ophthalmic Clinics, Ambulatory Surgical Centers, Homecare Settings) and Regional Analysis, 2023-2030

Product Code: HLSDT-38049973
Publish Date: 20-07-2023
Page: 200

Global Ocular Drug Delivery Market is valued approximately USD xxx billion in 2022 and is anticipated to grow with a healthy growth rate of more than xxx over the forecast period 2023-2030. Ocular Drug Delivery refers to a dosage form, vehicle, or system used to give or transport medication to the eye for the treatment of any condition that involves or affects vision. The eye is a very important organ that is susceptible to several illnesses. In addition to having an impact on the body, many eye conditions can cause blindness. It varies from straightforward implants for intraocular tissue to basic sterile eye drops for the ocular surface. The major factors driving the growth of the global ocular drug delivery technology market are low bioavailability of drugs in conventional ocular therapies, an increase in the incidence of glaucoma and macular degeneration, growing demand for targeted ocular drug delivery techniques, and an increase in the number of approvals from government regulations for new ocular drug delivery techniques. Favourable reimbursement policies and increased investment for the development of innovative drug delivery systems can assist drive market expansion.

Growing need for tailored ocular medicine delivery systems due to rise in glaucoma and macular degeneration rates. According to the World Health Organization in 2020, after cataract (35.2%) and uncorrected refractive error (20.3%), glaucoma is the third greatest cause of blindness (8.5%). According to estimate, 2.9 million individuals are blind from glaucoma, and 4 million people have some form of visual impairment. In the worldwide pool of vision loss, it was projected that the numbers would rise to 4.5 million for visual impairment and 3.2 million for blindness by 2020, respectively. Another recent systematic analysis reveals that glaucoma affects roughly 64 million individuals globally between the ages of 40 and 80, with that number anticipated to rise to 76 million by the year 2020. Additionally, the use of ocular penetration enhancers such as para-cellular pathways and phase transitions systems and the protective barrier systems of the human eye impede medication delivery effectiveness is projected to expand the market for ocular drug delivery systems. However, the high cost of production and drug related side effects stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Ocular Drug Delivery Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to availability of highly developed products and skilled professionals, growing governmental emphasis on R&D operations, well-established infrastructure for healthcare and research. Additionally, it is projected that an increase in the frequency of eye problems in this area would promote regional growth. Asia Pacific is expected to grow significantly during the forecast period, owing to the establishment of R&D facilities by prominent manufacturers in emerging nations, increasing prevalence of eye diseases, growing geriatric population, increasing healthcare expenditure, and favorable regulatory environment in the region.

Major market player included in this report are:
Valeant Pharmaceuticals International, Inc.
Taiwan Liposome Company, Ltd.
Ocular Therapeutix, Inc.
Graybug Vision Inc.
EyeGate Pharma
Clearside Biomedical, Inc.
Alimera Sciences
Envisia Therapeutics
Allergan, Plc.
AbbVie Inc.
Recent Developments in the Market:
Ø In February 2022, Alimera Sciences Europe Limited, its Irish-based European subsidiary, has launched ILUVIEN for non-infectious posterior uveitis in Spain through its distribution partner, Brill Pharma (Brill). Alimera Sciences, Inc. is a global pharmaceutical company whose mission is to be invaluable to patients, physicians, and partners concerned with maintaining better vision longer.
Ø In October 2021, Allergan, an Abbie company, announced that it will present new pooled analyses and post-hoc results from the Phase 3 trials of AGN-190584 (pilocarpine HCI ophthalmic solution 1.25%), an investigational novel treatment for presbyopia, at Academy 2021, the American Academy of Optometry’s annual meeting, which will be held November 3-6. Clinical data for near and intermediate vision, functional near vision, effectiveness for post-LASIK patients, and patient experience were all presented.
Global Ocular Drug Delivery Market Report Scope:
ü Historical Data – 2020 – 2021
ü Base Year for Estimation – 2022
ü Forecast period – 2023-2030
ü Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
ü Segments Covered – Technology, Formulation Type, Disease Type, End User, Region
ü Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa
ü Customization Scope – Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Technology:
Topical
Iontophoresis
Ocular Insert
Intraocular Implants
In Situ Gel Punctal Plugs
Others
By Formulation Type
Liposomes Nanoparticles
Solution
Emulsion
Suspension
Ointment
By Disease Type:
Glaucoma
Diabetic Retinopathy
Dry Eye Syndrome
Macular Degeneration
Cataract
Others
By End User:
Hospitals
Ophthalmic Clinics
Ambulatory Surgical Centers
Homecare Settings
By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Ocular Drug Delivery Market, by region, 2020-2030 (USD Billion)
1.2.2. Ocular Drug Delivery Market, by Technology, 2020-2030 (USD Billion)
1.2.3. Ocular Drug Delivery Market, by Formulation Type, 2020-2030 (USD Billion)
1.2.4. Ocular Drug Delivery Market, by Disease Type, 2020-2030 (USD Billion)
1.2.5. Ocular Drug Delivery Market, by End User, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Ocular Drug Delivery Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Ocular Drug Delivery Market Dynamics
3.1. Ocular Drug Delivery Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing incidence of glaucoma and macular degeneration
3.1.1.2. Approvals from government regulations for new ocular drug delivery techniques.
3.1.2. Market Challenges
3.1.2.1. High production cost of ocular drug delivery
3.1.2.2. Drug related side effects
3.1.3. Market Opportunities
3.1.3.1. Advancements in the use of ocular penetration enhancers
3.1.3.2. Protective barrier systems of the human eye impede medication delivery effectiveness
Chapter 4. Global Ocular Drug Delivery Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Ocular Drug Delivery Market, by Technology
5.1. Market Snapshot
5.2. Global Ocular Drug Delivery Market by Technology, Performance – Potential Analysis
5.3. Global Ocular Drug Delivery Market Estimates & Forecasts by Technology 2020-2030 (USD Billion)
5.4. Ocular Drug Delivery Market, Sub Segment Analysis
5.4.1. Topical
5.4.2. Iontophoresis
5.4.3. Ocular Insert
5.4.4. Intraocular Implants
5.4.5. In Situ Gel Punctal Plugs
5.4.6. Others
Chapter 6. Global Ocular Drug Delivery Market, by Formulation Type
6.1. Market Snapshot
6.2. Global Ocular Drug Delivery Market by Formulation Type, Performance – Potential Analysis
6.3. Global Ocular Drug Delivery Market Estimates & Forecasts by Formulation Type 2020-2030 (USD Billion)
6.4. Ocular Drug Delivery Market, Sub Segment Analysis
6.4.1. Liposomes & Nanoparticles
6.4.2. Solution
6.4.3. Emulsion
6.4.4. Suspension
6.4.5. Ointment
Chapter 7. Global Ocular Drug Delivery Market, by Disease Type
7.1. Market Snapshot
7.2. Global Ocular Drug Delivery Market by Disease Type, Performance – Potential Analysis
7.3. Global Ocular Drug Delivery Market Estimates & Forecasts by Disease Type 2020-2030 (USD Billion)
7.4. Ocular Drug Delivery Market, Sub Segment Analysis
7.4.1. Glaucoma
7.4.2. Diabetic Retinopathy
7.4.3. Dry Eye Syndrome
7.4.4. Macular Degeneration
7.4.5. Cataract
7.4.6. Others
Chapter 8. Global Ocular Drug Delivery Market, by End User
8.1. Market Snapshot
8.2. Global Ocular Drug Delivery Market by End User, Performance – Potential Analysis
8.3. Global Ocular Drug Delivery Market Estimates & Forecasts by End User 2020-2030 (USD Billion)
8.4. Ocular Drug Delivery Market, Sub Segment Analysis
8.4.1. Hospitals
8.4.2. Ophthalmic Clinics
8.4.3. Ambulatory Surgical Centers
8.4.4. Homecare Settings
Chapter 9. Global Ocular Drug Delivery Market, Regional Analysis
9.1. Top Leading Countries
9.2. Top Emerging Countries
9.3. Ocular Drug Delivery Market, Regional Market Snapshot
9.4. North America Ocular Drug Delivery Market
9.4.1. U.S. Ocular Drug Delivery Market
9.4.1.1. Technology breakdown estimates & forecasts, 2020-2030
9.4.1.2. Formulation Type breakdown estimates & forecasts, 2020-2030
9.4.1.3. Disease Type breakdown estimates & forecasts, 2020-2030
9.4.1.4. End User breakdown estimates & forecasts, 2020-2030
9.4.2. Canada Ocular Drug Delivery Market
9.5. Europe Ocular Drug Delivery Market Snapshot
9.5.1. U.K. Ocular Drug Delivery Market
9.5.2. Germany Ocular Drug Delivery Market
9.5.3. France Ocular Drug Delivery Market
9.5.4. Spain Ocular Drug Delivery Market
9.5.5. Italy Ocular Drug Delivery Market
9.5.6. Rest of Europe Ocular Drug Delivery Market
9.6. Asia-Pacific Ocular Drug Delivery Market Snapshot
9.6.1. China Ocular Drug Delivery Market
9.6.2. India Ocular Drug Delivery Market
9.6.3. Japan Ocular Drug Delivery Market
9.6.4. Australia Ocular Drug Delivery Market
9.6.5. South Korea Ocular Drug Delivery Market
9.6.6. Rest of Asia Pacific Ocular Drug Delivery Market
9.7. Latin America Ocular Drug Delivery Market Snapshot
9.7.1. Brazil Ocular Drug Delivery Market
9.7.2. Mexico Ocular Drug Delivery Market
9.8. Middle East & Africa Ocular Drug Delivery Market
9.8.1. Saudi Arabia Ocular Drug Delivery Market
9.8.2. South Africa Ocular Drug Delivery Market
9.8.3. Rest of Middle East & Africa Ocular Drug Delivery Market

Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
10.1.1. Company 1
10.1.2. Company 2
10.1.3. Company 3
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Valeant Pharmaceuticals International, Inc.
10.3.1.1. Key Information
10.3.1.2. Overview
10.3.1.3. Financial (Subject to Data Availability)
10.3.1.4. Product Summary
10.3.1.5. Recent Developments
10.3.2. Taiwan Liposome Company, Ltd.
10.3.3. Ocular Therapeutix, Inc.
10.3.4. Graybug Vision Inc.
10.3.5. EyeGate Pharma
10.3.6. Clearside Biomedical, Inc.
10.3.7. Alimera Sciences
10.3.8. Envisia Therapeutics
10.3.9. Allergan, Plc.
10.3.10. AbbVie Inc.
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now